Manufacturing, Nucleic Acids

>

Latest News

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
Bionova Scientific’s New pDNA Texas Facility Expected to Boost Cell and Gene Therapy Manufacturing Capacity

August 12th 2025

The newly launched facility is located in The Woodlands, Texas, and will produce plasmid DNA as well as strengthen biopharma supply chains.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Lilly Forms Strategic Collaboration with ViaNautis Bio to Develop Novel Genetic Cargo-based Therapeutics

October 30th 2024

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com
Merck KGaA Set to Acquire Mirus Bio in $600 Million Deal

May 23rd 2024

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Astellas and Poseida Therapeutics Partner to Develop Allogeneic Cell Therapies

May 6th 2024

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
Charles River Enters pDNA Manufacturing Deals with Axovia Therapeutics and Ship of Theseus

April 10th 2024

More News

Newman_Headshot-728233-1408616394360.jpg

The Status of the DNA Vaccine Field

Mark J. Newman
July 1st 2011

Plasmid DNA-encoding proteins offer many advantages, which are now being used in clinical trials.

Tab1_clone_instability-601147-1408648062640.jpg

Managing Cell Line Instability and Its Impact During Cell Line Development

Mark Leonard;Megan Hone;Cecilia Cooley;Kevin Mccarthy;Kerstin Crowe;Robin A. Heller-Harrison
June 2nd 2009

By considering stability as part of the cell line selection and cell banking paradigm, we can ensure that instability problems are not observed during clinical or commercial manufacturing.

Table1-601148-1408648057439.jpg

Production Strategies for Antibody Fragment Therapeutics

J.M. Liddell, PhD
June 2nd 2009

Microbial systems such as E. Coli and yeasts are most effective for producing antibody fragments.

Fig1_growth_curve_CHO-522161-1408671516849.jpg

Recombinant Protein Production Yields from Mammalian Cells: Past, Present, and Future

Sophie Nallet;Florian M. Wurm, PhD;David L. Hacker, PhD
June 2nd 2008

A discussion of past achievements and future expectations of recombinant protein production yields from mammalian cells.

<123
© 2025 MJH Life Sciences

All rights reserved.